Monday, 2nd, 2024 | 2:27AM Updated

The seeds of a Quillay soapbark tree are seen at the University of California in Berkeley, U.S.,
A Chilean tree holds hope for new vaccines - if supplies last

Down a dusty farm track in Chilean wine country, behind a wooden gate wrapped in chains, forestry experts are nursing a plantation of saplings whose bark holds the promise of potent vaccines.

Top Reasons to Start a Travel Blog: Read on to Know More
Top Reasons to Start a Travel Blog: Read on to Know More

If you are obsessed with traveling, you shouldn't shy away from starting a travel blog. After all, everyone loves to share their travel experiences on the web, so there's no reason to step back.

Coronavirus can transform pancreas cell function; certain genes may protect an infected person's spouse

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review.

8 Fun Ways Of Spending Time With Friends At Home
8 Fun Ways Of Spending Time With Friends At Home

Having friends is one of the best blessings of life. Your friends help you identify your interests and move forward in life. The stronger your friendship is, the better chances you have of growth and learning new things.

This page will have NATIVE ADS
Vials and syringes filled with the
Explainer - Who can get a COVID-19 vaccine booster in the United States?

The United States is rolling out booster shots https://www.reuters.com/world/us/us-cdc-advisers-recommend-covid-19-vaccine-boosters-65-older-high-risk-2021-09-23 of the Pfizer Inc and BioNTech SE COVID-19 vaccine for some Americans who received their second jab at least six months ago. The following explains the U.S. Food and Drug Administration and U.S. Centers for Disease Control and Prevention (CDC) decision on who can and should get shots now.

Vials with a sticker reading,
J&J says second shot boosts protection for moderate-severe COVID-19 to 94%

Johnson & Johnson said Tuesday a second shot of its COVID-19 vaccine given about two months after the first increased its effectiveness to 94% in the United States against moderate to severe forms of the disease.

Petri dish containing different steps and procedures by Nanyang Technology University (NTU) to turn durian husks into antimicrobial bandages, with final bandage product juxtaposed against commercial bandage
Scientists in Singapore transform fruit leftovers into antibacterial bandages

Scientists at Nanyang Technological University (NTU) in Singapore are tackling food waste by turning discarded durian husks into antibacterial gel bandages.

Stonehenge ancient stone circle is seen at dawn, near Amesbury, Wiltshire, Britain,
Major repair work starts at Stonehenge's stone circle

Vital repair work to fix cracks and holes in Stonehenge's prehistoric megaliths begins on Tuesday in one of the biggest conservation jobs at the world heritage site in decades, English Heritage said.

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S.
U.S. FDA may authorize COVID-19 vaccine for kids based on two months of safety data

U.S. heath regulators said children in clinical trials testing COVID-19 vaccines should be monitored for at least two months for side effects, suggesting that the agency is considering a quicker path to authorize the shot for emergency use than full approval.

A bicorne winter campaign hat which belonged to late French Emperor Napoleon Bonaparte is displayed ahead of an auction at Bonhams in Hong Kong, China
Newly discovered Napoleon hat with DNA previews in Hong Kong

A newly discovered hat with DNA evidence proving it belonged to the legendary European statesman and general Napoleon Bonaparte was previewed by auction house Bonhams in Hong Kong on Monday.

A person walks past a Pfizer logo amid the coronavirus disease (COVID-19) pandemic in the Manhattan borough of New York City, New York, U.S.
Pfizer, Merck launch new trials of oral COVID-19 drugs

Pfizer Inc and Merck & Co Inc announced on Wednesday new trials of their experimental oral antiviral drugs for COVID-19 as the race to develop an easy-to-administer treatment for the potentially fatal illness heats up.

A jararacussu snake, whose venom is used in a study against the coronavirus disease (COVID-19), is seen at Butantan Institute in Sao Paulo
Brazilian viper venom may become tool in fight against coronavirus, study shows

Brazilian researchers have found that a molecule in the venom of a type of snake inhibited coronavirus reproduction in monkey cells, a possible first step toward a drug to combat the virus causing COVID-19.

Pfizer logo seen outside their building in Manhattan, New York City, New York, U.S.,
Pfizer study shows skin disease drug more effective than Regeneron rival

Pfizer Inc's experimental drug to treat patients with moderate-to-severe atopic dermatitis met the main goals of improving symptoms in adult patients compared to a rival treatment from Regeneron Pharmaceutical Inc.

A nurse immuniser administers the AstraZeneca vaccine to a patient at a coronavirus disease (COVID-19) vaccination clinic at the Bankstown Sports Club
WHO says no conclusive data yet on need for COVID-19 booster shot

The World Health Organization Director General Tedros Adhanom Ghebreyesus said on Wednesday that the data on the benefits and safety of a COVID-19 vaccine booster shot is inconclusive.

Why Simone Biles' Mental Health Message Is Vital For Aspiring Athletes
Why Simone Biles' Mental Health Message Is Vital For Aspiring Athletes

Four-time Olympic champion Simone Biles is all anyone can talk about. The US gymnastics champion who is known for her creative floor routines and flawless balance beam performances pulled out of the women's team final, alongside the individual all-around final after scoring her lowest Olympic vault score so far.

In Case You Missed It

Real Time Analytics